SRE
SRE: Sagara Kevin C. discloses securities transactions
Sagara Kevin C. reported Grant or award in SEMPRA: 160.15 units of Phantom Shares (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
LoadingLoadingLoadingSRE
Sagara Kevin C. reported Grant or award in SEMPRA: 160.15 units of Phantom Shares (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
SRE
Weaving Anya reported Grant or award in SEMPRA: 160.15 units of Phantom Shares (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
SRE
YARDLEY JAMES C reported Grant or award in SEMPRA: 160.15 units of Phantom Shares (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
IBEX
Ringman Michael reported Grant or award in IBEX Ltd: 9038 units of Common Shares, dated 2026-09-30. The full Form 4 contains 2 transaction entries.
MMS
Mutryn David reported Tax/exercise withholding in MAXIMUS, INC.: 4749.296 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
LEEEF
MENDOLA ROBERT JAMES JR reported Other (see filing) in Leef Brands Inc.: 1224 units of Series A1 Preferred Shares, dated 2026-05-29. The full Form 4 contains 1 transaction entry.
GH
Talasaz AmirAli reported Exercise or conversion in Guardant Health, Inc.: 2817 units of Common Stock, dated 2026-09-30. The full Form 4 contains 8 transaction entries.
GH
Bell Michael Brian reported Exercise or conversion in Guardant Health, Inc.: 2085 units of Common Stock, dated 2026-10-01. The full Form 4 contains 7 transaction entries.
TECX
Ruddy Marcella K. reported Tax/exercise withholding in Tectonic Therapeutic, Inc.: 525 units of Common Stock, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
ECL
McKibben Tracy B reported Grant or award in ECOLAB INC.: 131.17 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
GH
Chudova Darya reported Exercise or conversion in Guardant Health, Inc.: 1340 units of Common Stock, dated 2026-10-01. The full Form 4 contains 9 transaction entries.
APC
Maurer Carlos A. reported 582 shares of Class A common stock in ARKO Petroleum Corp. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
APC
HEYER ANDREW R reported 1,247 shares of Class A common Stock, par value $0.0001 per share in ARKO Petroleum Corp. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
APC
Rogers Kirk T. reported 332 shares of Class A common Stock, par value $0.0001 per share in ARKO Petroleum Corp. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
ABBV
RAPP EDWARD J reported Grant or award in AbbVie Inc.: 129 units of Stock Equivalent Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.
APC
FRIEDMAN AVRAM Z reported 1,247 shares of Class A, Common Stock, par value $0.0001 per share in ARKO Petroleum Corp. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
BE
WARNER CYNTHIA J reported 83 shares of Common Stock in Bloom Energy Corp as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
ABBV
Quaggin Susan E reported Grant or award in AbbVie Inc.: 59 units of Stock Equivalent Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.
BE
IMMELT JEFFREY R reported 81 shares of Common Stock in Bloom Energy Corp as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 2, 2026. These were stock awards, not open-market purchases.
BE
Joshi Aman reported Sale in Bloom Energy Corp: 8437 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
GH
Freeman Chris reported Exercise or conversion in Guardant Health, Inc.: 1929 units of Common Stock, dated 2026-10-01. The full Form 4 contains 9 transaction entries.
RNXT
Marton Laurence reported Grant or award in RenovoRx, Inc.: 55924 units of Stock Options (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
RNXT
RYAN UNA S reported Grant or award in RenovoRx, Inc.: 55924 units of Stock Options (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
RNXT
Spiegel Robert J. reported Grant or award in RenovoRx, Inc.: 55924 units of Stock Options (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
